Shares of JPMorgan Chase & Co. closed 2.1 percent higher on Friday and rose by 50 cents to US$62.70 on news that James Dimon, the chief executive of the bank, has no evidence of cancer on his body.

It is a turnaround from just three months ago when Dimon informed employees of the largest U.S. bank by asset that he has throat cancer. The basis of his announcement, done through an email to bank workers, were several rounds of laboratory tests such as CT scan and PET scan.

Like Us on Facebook

Dimon wrote in the memo, quoted by the New York Times, "The good news is that the results came back completely clear, showing no evidence of cancer in my body."

He said the monitoring of his health, specifically if the cancer recurs, would go on for several years, but so far, "the results are extremely positive," while the prognosis is excellent.

Dr. Erich Sturgis, a professor at the Head & Neck Surgery Department of the University of Texas MD Anderson Cancer Center in Houston and not involved with Dimon's treatment, told the Wall Street Journal that when results are completely clear at this stage, chances for the cancer to return is very slim.

The 58-year-old Dimon took the occasion to remind JPMorgan employees to value their health first since "nothing is more important."

While undergoing treatment, Dimon still remained as chief executive - a position he has held since the mid-2000s - but cut back on his schedule. However, in the past few weeks, he had been slowly going back to his normal schedule.

Besides the memo, Dimon also shared his healing and recovery twice. First, on Thursday night at the operating committee meeting of JPMorgan and second, on Friday, at the bank's internal CEO conference in New York where about 200 attendees applauded the good news.

Aside from the positive health news of Dimon, the upbeat jobs report on Friday morning also boosted shareprices of JPMorgan.

Tagsjames dimon, JP Morgan Chase, throat cancer